BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30864020)

  • 21. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
    Ciurescu D; Condruz S; Irimie M
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 May; 33(3):actaapa.2024.14. PubMed ID: 38808531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin.
    Fine JD; Johnson LB; Weiner M; Stein A; Suchindran C
    J Am Acad Dermatol; 2004 Apr; 50(4):563-71. PubMed ID: 15034505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
    Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
    Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
    Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
    Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma in recessive dystrophic epidermolysis bullosa, presenting as an ulcer that appears to be filled with granulation tissue.
    Kalisiak MS; Edwards D; Lin AN
    J Cutan Med Surg; 2003; 7(3):229-31. PubMed ID: 12704532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study.
    Filoni A; Cicco G; Cazzato G; Bosco A; Lospalluti L; Tucci M; Cimmino A; Foti C; Marzullo A; Bonamonte D
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
    Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
    Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
    Welponer T; Weber DD; Trattner L; Tockner B; Aminzadeh-Gohari S; Leb-Reichl V; Kaufmann A; Zauner R; Wimmer M; Wally V; Felder TK; Strunk D; Koller U; Bauer JW; Kofler B; Guttmann-Gruber C; Piñon Hofbauer J
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):112-123. PubMed ID: 37669776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP; O'Toole EA
    Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic squamous cell carcinoma resembling angiosarcoma complicating dystrophic epidermolysis bullosa.
    McGrath JA; Schofield OM; Mayou BJ; McKee PH; Eady RA
    Dermatologica; 1991; 182(4):235-8. PubMed ID: 1884860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cutaneous squamous cell carcinomas: a complication of severe forms of hereditary epidermolysis bullosa].
    Bourrat E
    Soins; 2023 Nov; 68(880):36-38. PubMed ID: 37931996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.
    Illmer J; Zauner R; Piñón Hofbauer J; Wimmer M; Gruner S; Ablinger M; Bischof J; Dorfer S; Hainzl S; Tober V; Bergson S; Sarig O; Samuelov L; Guttmann-Gruber C; Shalom-Feuerstein R; Sprecher E; Koller U; Laimer M; Bauer JW; Wally V
    Br J Dermatol; 2023 Dec; 190(1):80-93. PubMed ID: 37681509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
    Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
    Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
    Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
    Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
    J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
    Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
    Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous cell carcinoma developing in epidermolysis bullosa dystrophica.
    Yoshioka K; Kono T; Kitajima J; Nakagawa K; Yashiro N; Taniguchi S; Furukawa M; Hamada T
    Int J Dermatol; 1991 Oct; 30(10):718-21. PubMed ID: 1955228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.